Enanta Pharmaceuticals
ENTA
#8126
Rank
A$0.52 B
Marketcap
A$17.89
Share price
3.31%
Change (1 day)
1.06%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -A$74.12 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are A$65.25 Million. In 2025 the company made an earning of -A$91.53 Million, an increase over its 2024 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$74.12 Million-19.03%
2025 -A$91.53 Million-34.07%
2024 -A$0.14 Billion-23.87%
2023 -A$0.19 Billion4.39%
2022 -A$0.18 Billion-4.4%
2021 -A$0.19 Billion91.12%
2020 -A$95.62 Million-407.13%
2019 A$31.13 M-78.63%
2018 A$0.14 B117.97%
2017 A$66.84 M-574.65%
2016 -A$14.09 Million-110.83%
2015 A$0.13 B-4.5%
2014 A$0.13 B-638.53%
2013 -A$25.29 Million-137.98%
2012 A$66.57 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.50 B-52,291.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.21 B-31,011.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
A$12.44 B-17,423.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$7.21 B-10,144.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.00 B-15,414.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.04 B-23,818.01%๐Ÿ‡บ๐Ÿ‡ธ USA